Active, Not Recruiting
Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
NCT03707938
- Conditions
- ALK Gene Rearrangement, Advanced Lung Carcinoma, Bronchial Neoplasms, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States